The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration.

To support the global program to eliminate lymphatic filariasis (LF), well-monitored demonstration projects are important for defining the relationship between coverage and reductions in microfilaremia. We are using mass treatment with diethylcarbamazine (DEC) and albendazole in an effort to eliminate LF from Leogane, Haiti. Wuchereria bancrofti microfilaremia prevalence at baseline ranged from 0.8% to 15.9% in four sentinel sites. After three rounds of DEC-albendazole mass drug administration (MDA), both microfilaremia prevalence and intensity decreased dramatically. Mild and moderate adverse reactions after treatment were common, especially after the first MDA, but decreased after subsequent MDAs. Drug coverage for the first year was estimated to be 72%, but concerns about adverse reactions appeared to decrease drug coverage in the second MDA. As a result of community education efforts that focused on providing a greater understanding of adverse reactions, coverage increased dramatically for the third round. Program efficiency increased substantially; the costs per person treated for three rounds of MDA were 2.23 US dollars, 1.96 US dollars, and 1.30 US dollars per person, respectively. The Leogane experience highlights the importance of adapting community education and mobilization campaigns to achieve and maintain good coverage.

[1]  D. Addiss,et al.  Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs. , 2004, The American journal of tropical medicine and hygiene.

[2]  D. Chadee,et al.  Evidence for the interruption of transmission of lymphatic filariasis among schoolchildren in Trinidad and Tobago. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[3]  Michael J Beach,et al.  Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence , 2004, Filaria journal.

[4]  L. Waller,et al.  Community- and individual-level determinants of Wuchereria bancrofti infection in Leogane Commune, Haiti. , 2004, The American journal of tropical medicine and hygiene.

[5]  J. Habbema,et al.  Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. , 2003, The Journal of infectious diseases.

[6]  M. Deming,et al.  Comparison of methods for estimating drug coverage for filariasis elimination, Leogane Commune, Haiti. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  D. Addiss,et al.  Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000. , 2003, The American journal of tropical medicine and hygiene.

[8]  M. Alpers,et al.  Mass treatment to eliminate filariasis in Papua New Guinea. , 2002, The New England journal of medicine.

[9]  D. Molyneux,et al.  Lymphatic filariasis elimination: progress in global programme development. , 2002, Annals of tropical medicine and parasitology.

[10]  K. R. Brown,et al.  Ivermectin: effectiveness in lymphatic filariasis , 2000, Parasitology.

[11]  A. Srividya,et al.  Cost of mass annual single dose diethylcarbamazine distribution for the large scale control of lymphatic filariasis. , 2000, The Indian journal of medical research.

[12]  E. Ottesen,et al.  The role of albendazole in programmes to eliminate lymphatic filariasis. , 1999, Parasitology today.

[13]  G. Weil,et al.  The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis. , 1997, Parasitology today.

[14]  B. Duke,et al.  Strategies and tools for the control/elimination of lymphatic filariasis. , 1997, Bulletin of the World Health Organization.

[15]  D. Meyrowitsch,et al.  Cost and cost effectiveness of mass diethylcarbamazine chemotherapy for the control of bancroftian filariasis: comparison of four strategies in Tanzania , 1996, Tropical medicine & international health : TM & IH.

[16]  Cao Wc,et al.  EPIDEMIOLOGICAL SURVEILLANCE OF FILARIASIS AFTER ITS CONTROL IN SHANDONG PROVINCE, CHINA , 1994 .

[17]  E. Chernin The disappearance of bancroftian filariasis from Charleston, South Carolina. , 1987, The American journal of tropical medicine and hygiene.

[18]  R. Webber Eradication of Wuchereria bancrofti infection through vector control. , 1979, Transactions of the Royal Society of Tropical Medicine and Hygiene.